scholarly journals Fetal cells in the maternal circulation: feasibility for prenatal diagnosis

1999 ◽  
Vol 105 (3) ◽  
pp. 574-583 ◽  
Author(s):  
Diana W. Bianchi
1995 ◽  
Vol 7 (2) ◽  
pp. 77-86 ◽  
Author(s):  
D Gänshirt ◽  
HSP Garritsen ◽  
W Holzgreve

Since the introduction of ultrasound into obstetrics during the 1960s, there has been rapid progress in the detection of genetic and nongenetic defects in utero. With the development of sampling procedures like amniocentesis, chorionic villus sampling (CVS) and fetal blood sampling, the obstetrician has been able to obtain fetal tissue and the parallel improvement in laboratory techniques has allowed the diagnosis of chromosomal anomalies and single gene defects from fetal cells. Amniocentesis and CVS have become well established techniques for routine prenatal diagnosis of chromosomal and metabolic disorders and fetal tissue is now accessible throughout all three trimesters.


1997 ◽  
Vol 17 (4) ◽  
pp. 389-389 ◽  
Author(s):  
A. Pezzolo ◽  
F. Santi ◽  
V. Pistoia ◽  
P. De Biasio

2005 ◽  
Vol 53 (3) ◽  
pp. 337-339 ◽  
Author(s):  
Esther Guetta ◽  
Liat Gutstein-Abo ◽  
Gad Barkai

Prenatal diagnosis based on rare fetal cells in maternal blood is currently not a feasible option. An effort was made to improve cell yields by targeting trophoblast cells. After sorting, the HLA-G-positive cell fraction was analyzed directly or after culture. In situ hybridization technology was applied to prove fetal cell source in samples from women carrying a male fetus and to predict gender in samples without previous knowledge of fetal sex. In vitro culture led to a significant increase in fetal cells and accurate gender prediction in 93% of these samples. This approach might be useful for non-invasive prenatal diagnosis.


Diagnostics ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. 2239
Author(s):  
Giulia Sabbatinelli ◽  
Donatella Fantasia ◽  
Chiara Palka ◽  
Elisena Morizio ◽  
Melissa Alfonsi ◽  
...  

Prenatal diagnosis plays a crucial role in clinical genetics. Non-invasive prenatal diagnosis using fetal cells circulating in maternal peripheral blood has become the goal of prenatal diagnosis, to obtain complete fetal genetic information and avoid risks to mother and fetus. The development of high-efficiency separation technologies is necessary to obtain the scarce fetal cells from the maternal circulation. Over the years, multiple approaches have been applied, including choice of the ideal cell targets, different cell recovering technologies, and refined cell isolation yield procedures. In order to provide a useful tool and to give insights about limitations and advantages of the technologies available today, we review the genetic research on the creation and validation of non-invasive prenatal diagnostic testing protocols based on the rare and labile circulating fetal cells during pregnancy.


Placenta ◽  
1993 ◽  
Vol 14 (4) ◽  
pp. A24
Author(s):  
D. Gänshirt-Ahlert ◽  
R. Börjesson-Stoll ◽  
M. Burschyk ◽  
A. Dohr ◽  
H.S.P. Garritsen ◽  
...  

2005 ◽  
Vol 16 (2) ◽  
pp. 151-177 ◽  
Author(s):  
ALEC McEWAN

Schmorl is generally credited with being the first to report finding fetal cells in maternal blood. In 1893 he identified trophoblasts in the pulmonary circulation of women who had died of eclampsia. Years later, in 1969, Walnowska identified Y chromosomes in lymphocytes isolated from the blood of pregnant women carrying male fetuses and this was repeated by Herzenberg in 1979 in white blood cells recognised as fetal by their surface HLA-A2 expression. Other sporadic reports followed but not until the 1990's did investigation into harvesting fetal cells from maternal blood begin in earnest. The aim of this article is to review the progress made in isolating and analysing these cells for the purposes of prenatal diagnosis.


2021 ◽  
pp. 60.1-60.11
Author(s):  
Gian Carlo Di Renzo ◽  
Elena Picchiassi ◽  
Michela Centra ◽  
Giuliana Coata

Sign in / Sign up

Export Citation Format

Share Document